Evidence map›Paper›PMID 36849900›Full record

ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2023

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization.

Dana Albon, Lijia Zhang, James Patrie, Marieke Jones, Z Galvin Li, Emily Noonan, Larry Borish

Open access · goldAbstract read
In one paragraph

Article in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Role of theInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. Wound repair and immune function in theFrontiers in cellular and infection microbiology · 2025
    Review
  5. Article
  6. The impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dana AlbonDepartments of Medicine, University of Virginia School of Medicine, 800546, Charlottesville, VA, 22908, USA. da9zj@uvahealth.org.ORCID http://orcid.org/0000-0001-9055-3247
Lijia ZhangDepartment of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
James PatriePublic Health Sciences, University of Virginia, Charlottesville, VA, USA.
Marieke JonesPublic Health Sciences, University of Virginia, Charlottesville, VA, USA.
Z Galvin LiDepartment of Statistics, University of Virginia, Charlottesville, VA, USA.
Emily NoonanDepartments of Medicine, University of Virginia School of Medicine, 800546, Charlottesville, VA, 22908, USA.
Larry BorishDepartments of Medicine, University of Virginia School of Medicine, 800546, Charlottesville, VA, 22908, USA.
University of Virginia · USVirginia Commonwealth University · US

Funding

Clinical response to rhinovirus challenge in human asthmaticsU01AI123337 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2016 to 2020
$3.6M
Lung rhinovirus (RV) infection identifies pre-school children with type 2 inflammation at risk for the development of asthmaR21AI151496 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C, TEAGUE, WILLIAM GERALD · 2020 to 2021
$444k
Protracted clinical and inflammatory response to rhinovirus challenge in human asthmaticsR56AI158519 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2022 to 2022
$323k
National Institute for Health Care Management Foundation UO1 AI123337NIAID NIH HHS R21 AI151496NIAID NIH HHS R56 AI158519NIAID NIH HHS U01 AI123337
6 · The paper itself

Abstract

backgroundThe Cystic Fibrosis Foundation Patient Registry (CFFPR) reports a high prevalence of asthma (34.6%) in people with Cystic Fibrosis (PwCF). While our current understanding of this relationship is limited, a type 2 inflammatory (T2) phenotype has often been identified in CF patients. RESEARCH QUESTION: This study aimed to evaluate the relationship between the eosinophilic CF T2 inflammatory phenotype and CF-related pulmonary outcomes and microbiological data. STUDY DESIGN AND

methodsWe conducted a retrospective chart review of adult patients with CF (18 and older; n = 93) receiving their care at University of Virginia Medical Center adult program from January, 2013 through December, 2018. Data collected included demographic data, CFTR (CF transmembrane conductance regulator) mutation, CF comorbidities, medications, Absolute Eosinophil Counts (AEC) in cells/µL and Immunoglobulin E (IgE) levels in IU/mL.

resultsOf 93 patients screened for study eligibility, 74 were included in the final analysis; 19 patients were excluded due to lack of longitudinal data across the study timeline. Lung function decline correlated with increased AEC (p < 0.001) and IgE (p < 0.001) even when adjusting for covariates: age, gender, presence of Pseudomonas spp., MRSA, other bacterial spp., Aspergillus spp., and other fungi (p < 0.001). Univariate analysis demonstrated that people with CF who experienced more than 2 exacerbations requiring hospitalizations and/or intravenous antibiotics a year were more likely to have high AEC (p = 0.018). Logistic regression showed that as AEC increases, the probability that the measurement was taken during a CF exacerbation increases (p = 0.0039). A linear mixed model showed that each additional annual exacerbation event increased on average the log IgE by 0.04. (p = 0.015). This finding remained stable in a multivariate model (p = 0.0145). When adjusted for atopy, log IgE increases as the number of exacerbation events increases (p = 0.022). There was no association between AEC and IgE and microbiological colonization.

interpretationThis study has shown that in CF patients, T2 inflammation based on serum AEC and IgE correlated with pulmonary exacerbations requiring hospitalizations and/or intravenous antibiotics, independent of bacterial airway colonization. In addition, lung function decline correlated with increased IgE and AEC. Further studies are needed to explore these correlations and potential impact on treatment.

Indexed as

BacteriaCystic fibrosisEosinophilFungiImmunoglobulin EPulmonary exacerbationType 2 inflammation

Identifiers

PMID36849900
PMCPMC9969710
OpenAlexW4322495826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.